I can easily wait until Feb or even Mar so long as they have their ducks in a role and the outcome is positive. Haste makes waste with the FDA, so I'd rather see this done right.
Revive Therapeutics (RVVTF) will not publicly release the data on the interim analysis before it’s had a chance to be reviewed by the Independent Data and Safety Monitoring Board (DSMB).
Only after will RVVTF publicly release the data with the DSMB’s review and recommendations, which also may include RVVTF has started the process to file for an Emergency Use Authorization (EUA).
I'm like most here and was hoping for news in late December. Thus I am disappointed we are in mid January with no news yet. I am hoping for news this week but who knows if it will come. Any thought to the possibility of MF releasing the 210 data along with EUA approval or fda at the same time?